Cost-Containment Solutions

COST-CONTAINMENT SOLUTIONS

Discover our cost-containment solutions for high-cost drugs.

Specialty drugs drive over 50% of pharmacy costs for just 2% of members. We connect you with proven partners and programs, managing and optimizing performance to ensure maximum value and results.

International Filling

Another option to help decrease your costs while providing your members with access to important drugs is international filling. Often times, sourcing manufacturers in other countries can provide the same safe, clinically effective options at a significantly lower cost to you and the member.

Specialty Drug Solutions

On average, specialty drug spend makes up 50% of your costs but only 2% of your overall utilization, with these costs increasing 10-14% each year. Our specialty solutions, including variable copay, manufacturer assistance and patient assistant programs leverages the full value assistance to reduce the amount owed by the plan.

Medical Rebates

Our robust medical rebate program can help you reduce costs by accessing rebates on over 60+ drugs including biosimilars for oncology and other specialty medications. We harness the power of our relationships with pharmaceutical manufacturers to secure optimal medical rebates, leading to meaningful savings.

Integrated Cash

The best prescription prices for generics are often found through cash networks and not your insurance plan. We offer access to different cash network solutions to find the right match for your organizations’ prescription savings needs.

Pharmacogenomics

Pharmacogenomics harnesses the power of genetic insights to personalize medication selection and dosing, ensuring treatments are safer and more effective for individual patients. By integrating pharmacogenomics into pharmacy benefit strategies, we help optimize outcomes, reduce adverse reactions, and manage costs.

GLP1s for Weight Loss

At a time when the cost of groundbreaking drugs like GLP-1s and gene therapies are pushing healthcare budgets to the brink, Navion is uniquely positioned to help. Navion doesn’t just respond to skyrocketing pharmacy costs associated with new therapies—we anticipate them. By meticulously crafting programs that protect payers, our team ensures that innovation doesn’t come at the cost of financial stability.

Diabetes Management & Support

Diabetes management is more than just prescribing medication—it’s about choosing the right treatment for each patient. With an ever-growing list of diabetic drugs, benefit advisors need to stay informed about the different classes to ensure affordability for groups.

Cell & Gene Therapy

Gene therapies, which now dominate the FDA pipeline, offer promise of potential cures for conditions once deemed incurable. But as these therapies transition from targeting ultra-rare conditions to addressing more prevalent diseases, it’s critical for plan sponsors to prepare for financial risks.

CASE STUDY

Cost-Containment Client Success

Implemented specialty solutions to drive down cost, with limited member disruption.

1,000

Group Lives

$1.9M

Annual Plan Costs

$425K

Annual Savings for the Client

Future-Proof Pharmacy Benefits

Our expertise spans key areas essential to optimizing pharmacy benefits. From comprehensive clinical support and seamless account management to expert guidance on high-cost drugs, we provide the insights and strategies you need to stay ahead of rising costs and make informed decisions that drive long-term value.

Seamless Member & Account Support

Our team becomes an extension of your team, offering guidance and simplifying processes to ensure seamless member experiences, integration and ongoing success.

Clinical Oversight

Our clinicians regularly review and assess programs to ensure they remain effective in addressing cost challenges and aligned with the latest clinical guidelines and market trends.

Future-Focused

Our clinical team and Rx experts continuously monitor the FDA pipeline and emerging trends to anticipate and address upcoming cost challenges, ensuring our clients are always ready for shifts in the pharmaceutical landscape.